Skip to main content
Clinical Trials/NCT03929198
NCT03929198CompletedNot Applicable

Population-Based Lifestyle Intervention: Translation of the Pritikin Program to the Community- Pilot Study Protocol

Washington University School of Medicine1 site in 1 country54 target enrollmentStarted: September 27, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
54
Locations
1
Primary Endpoint
Blood Pressure

Study Overview

Brief Summary

The broad, long-term aims of this scope of work are to investigate the effects of the Pritikin Program to the general population. The study will test the effects on individuals from the community with dysfunctional lipids, blood pressure and glycemic control. To assess the effectiveness of the Pritikin Program in the community, the effects of Pritikin lifestyle intervention on overall health will be investigated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Dysfunctional lipids, blood pressure and glycemic control determined at a screening visit:
  • •Triglycerides > 150 mg/dL OR HDL <50 in females, <40 mg/dL in males
  • •Systolic blood pressure ≥130 mmHg OR diastolic blood pressure ≥80 mmHg (or on hypertension medication)
  • •HbA1c ≥5.7% or higher
  • •No diagnosis or treatment for cancer in the past year
  • •No diagnosis of mild cognitive impairment or dementia in the past year
  • •Ability to perform daily exercise, including aerobic activity and resistance exercise
  • •Non-smoker in the past year

Exclusion Criteria

  • •Positive exercise stress test

Arms & Interventions

Intervention

Experimental

The intervention group participated in a 6-week Pritikin diet, exercise program, and behavioral modification.

Intervention: Healthy Lifestyle (Other)

Control

No Intervention

This group did not receive any intervention.

Outcomes

Primary Outcomes

Blood Pressure

Time Frame: 6 weeks

Cholesterol

Time Frame: 6 weeks

Triglycerides

Time Frame: 6 weeks

Body Weight

Time Frame: 6 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials